Skip to main content
. Author manuscript; available in PMC: 2015 Jan 22.
Published in final edited form as: Int J Cancer Res. 2013;9(2):36–53. doi: 10.3923/ijcr.2013.36.53

Fig. 5.

Fig. 5

GZL inhibits the NF-κB activation through ROS independent pathway. The cells were treated for 5h at four different concentration levels of GZL and taxol. ROS was detected with fluorescent probe DCFH-DA at 485 nm emission wavelength and 530 nm excitation wavelength. Daunomycin was used as a positive control. Each experiment was carried out in triplicate. Values represent the means of fluorescence units (FU) ± SEM of triplicate samples from two separate experiments.